Medicine

Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today reported financial results for the quarter ended December 31, 2016

Straumann Group pursues global expansion strategy without MegaGen

Sanofi and Lonza Enter into a Strategic Partnership to Establish a Large-Scale Biologics Production Facility

Kuros receives clearance from the US FDA for MagnetOs allowing marketing in the United States

Roche receives EU approval of Alecensa (alectinib) for people with previously treated ALK-positive non-small cell lung cancer

Sonova continues to set new standards with innovative hearing solutions

Deaths from diabetes in the US may be three times higher than previously estimated. "Diabetes is a major feature on the landscape of American mortality."

Roche reports good results in 2016

Astellas Pharma Inc. today announced that it executed a license agreement with respect to an exclusive worldwide license for an AU-935 program with Auration Biotech, Inc.

Pirkko Mattila, Minister of Social Affairs and Health, will lead Finnish companies’ Team Finland visit to Dubai from 29 January until 1 February.

Kuros closes acquisition of Xpand creating a leading commercial-stage orthobiologics company

IBM Watson Health (NYSE: IBM) has signed a research initiative with the U.S. Food and Drug Administration (FDA) aimed at defining a secure, efficient and scalable exchange of health data using blockchain technology.